1. Home
  2. VLRS vs TNGX Comparison

VLRS vs TNGX Comparison

Compare VLRS & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLRS
  • TNGX
  • Stock Information
  • Founded
  • VLRS 2005
  • TNGX 2014
  • Country
  • VLRS Mexico
  • TNGX United States
  • Employees
  • VLRS N/A
  • TNGX N/A
  • Industry
  • VLRS Air Freight/Delivery Services
  • TNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLRS Consumer Discretionary
  • TNGX Health Care
  • Exchange
  • VLRS Nasdaq
  • TNGX Nasdaq
  • Market Cap
  • VLRS 671.0M
  • TNGX 723.2M
  • IPO Year
  • VLRS N/A
  • TNGX N/A
  • Fundamental
  • Price
  • VLRS $6.15
  • TNGX $6.94
  • Analyst Decision
  • VLRS Buy
  • TNGX Strong Buy
  • Analyst Count
  • VLRS 6
  • TNGX 6
  • Target Price
  • VLRS $8.18
  • TNGX $10.00
  • AVG Volume (30 Days)
  • VLRS 425.7K
  • TNGX 1.3M
  • Earning Date
  • VLRS 10-21-2025
  • TNGX 11-05-2025
  • Dividend Yield
  • VLRS N/A
  • TNGX N/A
  • EPS Growth
  • VLRS N/A
  • TNGX N/A
  • EPS
  • VLRS N/A
  • TNGX N/A
  • Revenue
  • VLRS $3,019,191,000.00
  • TNGX $24,296,000.00
  • Revenue This Year
  • VLRS N/A
  • TNGX $6.56
  • Revenue Next Year
  • VLRS $12.17
  • TNGX N/A
  • P/E Ratio
  • VLRS N/A
  • TNGX N/A
  • Revenue Growth
  • VLRS N/A
  • TNGX N/A
  • 52 Week Low
  • VLRS $3.49
  • TNGX $1.03
  • 52 Week High
  • VLRS $9.00
  • TNGX $11.92
  • Technical
  • Relative Strength Index (RSI)
  • VLRS 62.42
  • TNGX 56.91
  • Support Level
  • VLRS $6.08
  • TNGX $6.28
  • Resistance Level
  • VLRS $6.27
  • TNGX $7.05
  • Average True Range (ATR)
  • VLRS 0.18
  • TNGX 0.41
  • MACD
  • VLRS -0.03
  • TNGX -0.04
  • Stochastic Oscillator
  • VLRS 75.00
  • TNGX 57.89

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: